BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17917540)

  • 1. Childhood systemic sclerosis.
    Zulian F; Martini G
    Curr Opin Rheumatol; 2007 Nov; 19(6):592-7. PubMed ID: 17917540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic sclerosis and localized scleroderma in childhood.
    Zulian F
    Rheum Dis Clin North Am; 2008 Feb; 34(1):239-55; ix. PubMed ID: 18329543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Juvenile scleroderma].
    de Mâcedo PA; Shinjo SK; Goldenstein-Schainberg C
    Acta Reumatol Port; 2008; 33(3):289-97. PubMed ID: 18846006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis.
    Zulian F; Woo P; Athreya BH; Laxer RM; Medsger TA; Lehman TJ; Cerinic MM; Martini G; Ravelli A; Russo R; Cuttica R; de Oliveira SK; Denton CP; Cozzi F; Foeldvari I; Ruperto N
    Arthritis Rheum; 2007 Mar; 57(2):203-12. PubMed ID: 17330294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized scleroderma.
    Laxer RM; Zulian F
    Curr Opin Rheumatol; 2006 Nov; 18(6):606-13. PubMed ID: 17053506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on pediatric systemic sclerosis: similarities and differences from adult disease.
    Foeldvari I
    Curr Opin Rheumatol; 2008 Sep; 20(5):608-12. PubMed ID: 18698186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database.
    Martini G; Foeldvari I; Russo R; Cuttica R; Eberhard A; Ravelli A; Lehman TJ; de Oliveira SK; Susic G; Lyskina G; Nemcova D; Sundel R; Falcini F; Girschick H; Lotito AP; Buoncompagni A; Sztajnbok F; Al-Mayouf SM; Orbàn I; Ferri C; Athreya BH; Woo P; Zulian F;
    Arthritis Rheum; 2006 Dec; 54(12):3971-8. PubMed ID: 17133611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic sclerosis in childhood.
    Foeldvari I
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii28-9. PubMed ID: 16987828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic sclerosis--clinical course and treatment possibilities].
    Szymańska E; Maj M; Rudnicka L
    Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An update on systemic sclerosis].
    Kowal-Bielecka O
    Ann Acad Med Stetin; 2010; 56 Suppl 1():80-2. PubMed ID: 21365948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proposal of criteria for the classification of systemic sclerosis.
    Nadashkevich O; Davis P; Fritzler MJ
    Med Sci Monit; 2004 Nov; 10(11):CR615-21. PubMed ID: 15507853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the management of juvenile systemic sclerosis.
    Zulian F; Balzarin M; Birolo C
    Expert Rev Clin Immunol; 2017 Apr; 13(4):361-369. PubMed ID: 27690679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
    Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
    Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of childhood linear scleroderma to fatal systemic sclerosis.
    Mayorquin FJ; McCurley TL; Levernier JE; Myers LK; Becker JA; Graham TP; Pincus T
    J Rheumatol; 1994 Oct; 21(10):1955-7. PubMed ID: 7837166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleroderma in childhood: a 35-year history of cases and review of the literature.
    Bottoni CR; Reinker KA; Gardner RD; Person DA
    J Pediatr Orthop; 2000; 20(4):442-9. PubMed ID: 10912598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EULAR Scleroderma Trials and Research Group (EUSTAR): an international framework for accelerating scleroderma research.
    Tyndall A; Ladner UM; Matucci-Cerinic M
    Curr Opin Rheumatol; 2008 Nov; 20(6):703-6. PubMed ID: 18946332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding systemic sclerosis through gene expression profiling.
    Pendergrass SA; Whitfield ML; Gardner H
    Curr Opin Rheumatol; 2007 Nov; 19(6):561-7. PubMed ID: 17917536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on autoantibodies in systemic sclerosis.
    Walker JG; Fritzler MJ
    Curr Opin Rheumatol; 2007 Nov; 19(6):580-91. PubMed ID: 17917539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research.
    Avouac J; Kowal-Bielecka O; Landewe R; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M;
    Ann Rheum Dis; 2009 May; 68(5):629-34. PubMed ID: 18957486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive systemic sclerosis.
    Medsger TA
    Clin Rheum Dis; 1983 Dec; 9(3):655-70. PubMed ID: 6360519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.